However, “Claudin-Low” breast cancers, which present stem-like expression profiles (Fougner et al., 2020), displayed significantly higher ZFP36 expression levels than Luminal, Her2 and Basal subtypes (Figure 2C). This evidence concerns the gene ERBB2 and breast cancer.